Bayshore Medical Center Now Providing a Procedure to Prevent Heart Attack

What You Need to Know

The New Jersey Department of Health (NJDOH) has licensed Bayshore Medical Center to provide elective angioplasty.

This additional licensure enables cardiologists to perform diagnostic testing and if needed, necessary treatment during one visit. Recently, the medical center completed its first elective case successfully with the patient now home and recuperating well.

Bayshore’s cardiac Multi-Specialty Interventional Suite provides patients with advanced cardiac technology, an American College of Cardiology (ACC) Accredited Chest Pain Center with PCI, pacemaker procedures with a 5-Star rating from Healthgrades and cardiac rehabilitation services. The medical center received the ACC’s 2021 NCDR Chest Pain - MI Registry Platinum Quality award and the American Heart Association’s 2021 Get with the Guidelines- Heart Failure Gold Plus Award recognizing exemplary heart attack care and care for heart failure, respectively.

Hospitals providing angioplasty have arrangements in place with local facilities that provide open-heart surgery in case of emergency. Bayshore’s backup facility is Jersey Shore University Medical Center.  

In May 2021, the NJDOH enabled the state’s hospitals to begin an application process, including extensive data collection and a site survey, to receive licensure to become a full-service catheterization lab for diagnostic testing or add an elective angioplasty service to a preexisting emergency angioplasty service. Eight Hackensack Meridian Health medical centers in Middlesex, Monmouth, Ocean, Hudson and Essex counties have applied for expanded services.